{"@type":"Dataset","integmet_study":"MTBLS2262","mesh_chemical_id":["https://identifiers.org/mesh:D013256","https://identifiers.org/mesh:D008055","https://identifiers.org/mesh:D000438","https://identifiers.org/mesh:D010129"],"mesh_chemical_pubtator_kw":["steroid","lipid","alcohol","lipids","4-Aminobenzoic acid"],"mesh_disease_id":["https://identifiers.org/mesh:D016114","https://identifiers.org/mesh:D052439","https://identifiers.org/mesh:D000070603","https://identifiers.org/mesh:D056486","https://identifiers.org/mesh:D000076042"],"mesh_disease_pubtator_kw":["SONFH","lipid metabolism disorder","osteonecrosis of the femoral head","traumatic-induced ONFH","AONFH","TONFH"],"ncbi_taxonomy_id":["https://identifiers.org/taxonomy:9606"],"ncbi_taxonomy_pubtator_kw":["human","patients"],"source_id":"https://identifiers.org/metabolights:MTBLS2262","study_findings":"Altered lipid signatures and biomarkers identified in ONFH subgroups.","study_observation":"Plasma lipidomics in ONFH patients and healthy controls.","study_summary":"Plasma lipidomics in osteonecrosis of the femoral head.","study_title_original":"Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head"}